Jennifer E. Liu

Long-term cardiovascular consequences of cancer therapy-related cardiac dysfunction: insights from ventricular-arterial coupling and myocardial work.

Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients

Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies.

Association of Circulating Cardiomyocyte Cell-Free DNA With Cancer Therapy–Related Cardiac Dysfunction in Patients Undergoing Treatment for <i>ERBB2</i>-Positive Breast Cancer

Advances in Multimodality Imaging in Cardio-Oncology

Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

Racial and Socioeconomic Disparities in Cardiotoxicity Among Women With HER2-Positive Breast Cancer

Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils.

Strain Imaging in Cardio-Oncology

Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of <i>ERBB2</i>-Positive Breast Cancer

Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis

Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement

Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils

Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart

Cardiotoxicity of HER2-targeted therapies

Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging